These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 6424929

  • 1. Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line.
    DiSorbo DM, Harris NA, Nathanson L.
    Cancer Res; 1984 May; 44(5):1752-5. PubMed ID: 6424929
    [Abstract] [Full Text] [Related]

  • 2. Suppression of DNA synthesis in NEL-M1 human melanoma cells by triamcinolone acetonide.
    DiSorbo DM, Harris NA, Nathanson L.
    Cancer Res; 1985 Apr; 45(4):1633-7. PubMed ID: 3919942
    [Abstract] [Full Text] [Related]

  • 3. Effect of triamcinolone acetonide on the growth of NEL-M1 human melanoma cells cultured in the presence and absence of growth stimulatory agents.
    DiSorbo DM.
    Cancer Res; 1986 Aug; 46(8):3964-8. PubMed ID: 3015380
    [Abstract] [Full Text] [Related]

  • 4. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B, Lindbladh C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1983 Aug; 63(6):468-75. PubMed ID: 6198834
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of tyrosinase by dihydroxy phenyl derivatives.
    Karg E, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1989 Aug; 69(6):521-4. PubMed ID: 2575328
    [Abstract] [Full Text] [Related]

  • 6. In vitro growth inhibition of human malignant melanoma cells by glucocorticoids.
    DiSorbo DM, McNulty B, Nathanson L.
    Cancer Res; 1983 Jun; 43(6):2664-7. PubMed ID: 6850583
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase.
    Martínez JH, Solano F, García-Borrón JC, Iborra JL, Lozano JA.
    Biochem Int; 1985 Nov; 11(5):729-38. PubMed ID: 3937527
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
    Kovacs SA, Geekie KM, Oxenhandler RW, Agris PF.
    J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
    [Abstract] [Full Text] [Related]

  • 14. Modulation of tyrosinase activity and viral information by 5-iodo-deoxyuridine and L-dopa in a human melanoma cell line [proceedings].
    Van Tieghem N, Doyen A, Liteanu D, Cogniaux J, Frühling J.
    Arch Int Physiol Biochim; 1979 Oct; 87(4):857-8. PubMed ID: 93948
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
    Blagoeva PM.
    Neoplasma; 1977 Oct; 24(3):291-4. PubMed ID: 408715
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.